Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Visualizing DNA single- and double-strand breaks in the Flash comet assay by DNA polymerase-assisted end-labelling
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaceutisk biovetenskap.ORCID-id: 0000-0003-2471-1432
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaceutisk biovetenskap.ORCID-id: 0000-0002-3429-7856
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaceutisk biovetenskap.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi.
Visa övriga samt affilieringar
2024 (Engelska)Ingår i: Nucleic Acids Research, ISSN 0305-1048, E-ISSN 1362-4962, Vol. 52, nr 4Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

In the comet assay, tails are formed after single-cell gel electrophoresis if the cells have been exposed to genotoxic agents. These tails include a mixture of both DNA single-strand breaks (SSBs) and double-strand breaks (DSBs). However, these two types of strand breaks cannot be distinguished using comet assay protocols with conventional DNA stains. Since DSBs are more problematic for the cells, it would be useful if the SSBs and DSBs could be differentially identified in the same comet. In order to be able to distinguish between SSBs and DSBs, we designed a protocol for polymerase-assisted DNA damage analysis (PADDA) to be used in combination with the Flash comet protocol, or on fixed cells. By using DNA polymerase I to label SSBs and terminal deoxynucleotidyl transferase to label DSBs with fluorophore-labelled nucleotides. Herein, TK6-cells or HaCat cells were exposed to either hydrogen peroxide (H2O2), ionising radiation (X-rays) or DNA cutting enzymes, and then subjected to a comet protocol followed by PADDA. PADDA offers a wider detection range, unveiling previously undetected DNA strand breaks. Graphical Abstract

Ort, förlag, år, upplaga, sidor
Oxford University Press, 2024. Vol. 52, nr 4
Nationell ämneskategori
Farmaceutiska vetenskaper
Identifikatorer
URN: urn:nbn:se:uu:diva-528077DOI: 10.1093/nar/gkae009ISI: 001146868600001PubMedID: 38261985OAI: oai:DiVA.org:uu-528077DiVA, id: diva2:1858168
Forskningsfinansiär
CancerfondenTillgänglig från: 2024-05-15 Skapad: 2024-05-15 Senast uppdaterad: 2025-10-21Bibliografiskt granskad
Ingår i avhandling
1. Utilising DNA Modifying Enzymes for Method Development in Molecular Biology
Öppna denna publikation i ny flik eller fönster >>Utilising DNA Modifying Enzymes for Method Development in Molecular Biology
2025 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Method development plays a critical role in advancing molecular biology by enabling the detection, visualization, and interpretation of complex cellular processes. This dissertation focused on the development and optimization of methods based on DNA modifying enzymes to investigate DNA damage and protein–protein interactions—key mechanisms in genomic integrity, stress response, and gene regulation.

The first part of the work involved the development of Polymerase-Assisted DNA Damage Analysis (PADDA), a method combining the comet assay with enzymatic labelling to distinctively detect DNA single-strand breaks (SSBs) and double-strand breaks (DSBs) with fluorescence microscopy.

For a genome-wide detection of SSBs, a novel sequencing-based method—Sequence-Templated Erroneous End-Labelling sequencing (STEEL-seq) was developed. The method is based on an engineered, artificial DNA polymerase, Sloppymerase. Its highly error-prone activity allows for DNA synthesis in absence of a specific nucleotide (e.g. dATP), creating unique patterns of mismatches directly downstream of an SSB. These mismatches can be detected after DNA sequencing analysis and give information about bona fide SSBs. The method was validated using multiple sequencing platforms, revealing enrichment of SSBs at promoter regions of actively transcribed genes.

The final part of the work covers a new antibody-based proximity assay for the detection of endogenous protein-protein interactions - Enzyme-Activated Proximity of Oligonucleotides Sensing (EPOS). Across multiple cellular models, EPOS could produce robust results for the detection of PPIs with higher resolution, improved dynamic range and increased sensitivity compared with in situ proximity ligation assay.

Collectively, the methods developed during this project demonstrate the transformative potential of enzymatic tools in molecular biology. By enabling more precise and accessible analysis of DNA damage and protein interactions, these approaches provide valuable platforms for future research in genomics, cell biology, and biomedical science.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2025. s. 60
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 388
Nyckelord
Method development, molecular biology, DNA damage, protein-protein interactions
Nationell ämneskategori
Farmaceutiska vetenskaper
Forskningsämne
Molekylär biovetenskap
Identifikatorer
urn:nbn:se:uu:diva-570057 (URN)978-91-513-2645-0 (ISBN)
Disputation
2025-12-11, B22, BMC, Husargatan 3, Uppsala, 09:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2025-11-18 Skapad: 2025-10-21 Senast uppdaterad: 2025-11-18

Open Access i DiVA

fulltext(1665 kB)657 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1665 kBChecksumma SHA-512
99f67cde320bd74fe650d2ec919153e8d967176521590f2711d7fdee4ec53154cbb9a506c38cc0fc8c0c73df0427a0fac110558395e0876b53679b2cf77103d4
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Person

Bivehed, ErikHellman, BjörnWenson, LeonieStenerlöw, BoSöderberg, OlaHeldin, Johan

Sök vidare i DiVA

Av författaren/redaktören
Bivehed, ErikHellman, BjörnWenson, LeonieStenerlöw, BoSöderberg, OlaHeldin, Johan
Av organisationen
Institutionen för farmaceutisk biovetenskapInstitutionen för immunologi, genetik och patologi
I samma tidskrift
Nucleic Acids Research
Farmaceutiska vetenskaper

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 659 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 542 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf